Medical devices, healthcare technology and the business of care
PMA approval · P140031

SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES

Edwards Lifesciences, LLC · Decision date Jun 17, 2015

FDA DECISIONP140031

What did the FDA approve?

FDA records P140031 as an original PMA application. The recorded decision is approval, dated Jun 17, 2015.

FDA approval order statement

APPROVAL FOR THE EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE, MODEL 9600TFX, AND ACCESSORIES. THIS DEVICE IS INDICATED FOR RELIEF OF AORTIC STENOSIS IN PATIENTS WITH SYMPTOMATIC HEART DISEASE DUE TO SEVERE NATIVE CALCIFIC AORTIC STENOSIS WHO ARE JUDGED BY A HEART TEAM, INCLUDING A CARDIAC SURGEON, TO BE AT HIGH OR GREATER RISK FOR OPEN SURGICAL THERAPY (I.E., SOCIETY OF THORACIC SURGEONS OPERATIVE RISK SCORE 8% OR AT A 15% RISK OF MORTALITY AT 30 DAYS).
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Jun 17, 2015

FDA source record

Regulatory record facts

Identifier
P140031
Regulatory pathway
Premarket approval application
Product code
NPT
Decision code
APPR
Decision date
Jun 17, 2015
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Aortic valve, prosthesis, percutaneously delivered.

Product code
NPT
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P140031 received

    Application receipt date recorded by FDA.

  2. P140031 · FDA decision

    APPR

  3. P140031/S209 · Related supplement

    Edwards Crimper (9600LDS23, 9600LDS26, 9600LDS29, 9750CM20, 9750CM23, 9750CM26, 9750CM29)

  4. P140031/S202 · Related supplement

    Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve

  5. P140031/S210 · Related supplement

    Edwards SAPIEN 3 Transcatheter Heart Valve (9600TFX), Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (9750TFX)

Timeline entries are records held by MedtechLedger for P140031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140031

Explore the linked device profile

Other records with product code NPT

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records